Association of Four Medication Classes and Non-suicidal Self-injury in Adolescents with Affective Disorders – A Retrospective Chart Review

Abstract

Background Non-suicidal self-injury (NSSI) behaviour is frequently observed in children and adolescents with psychiatric conditions. Affected individuals are regularly treated with psychotropic drugs, although the impact of these agents on NSSI behaviour remains elusive.

Methods We performed a retrospective chart review from clinical routine data in a large cohort (N=1140) of adolescent inpatients with primary affective and non-affective psychiatric disorders according to ICD-10 (mean age=15.3±1.3 years; 72.6% female). Four separate mixed regression models compared the frequency of NSSI between treatment periods without any medication and four medication categories (benzodiazepines, selective serotonin reuptake inhibitors (SSRIs), high- and low-potency antipsychotics).

Results In those individuals with affective disorders as the primary diagnosis, periods without medication were associated with significantly lower NSSI/day compared to all four other medication conditions (benzodiazepines p<10⁻⁸, antidepressants/SSRIs p=0.0004, high-potency antipsychotics p=0.0009, low-potency antipsychotics p<10 ⁻⁴). In individuals with a primary diagnosis other than an affective disorder, NSSI was significantly lower during the period without medication compared to the treatment periods with benzodiazepines (p=0.005) and antidepressants/SSRIs (p=0.01). However, NSSI rates in the no-medication condition were comparable to NSSI rates under high-potency (p=0.89) and low-potency antipsychotics (p=0.53).

Conclusions The occurrence of NSSI correlates with the treatment with a psychotropic drug in children and adolescents with psychiatric disorders. Due to the retrospective design, it remains elusive to what extent psychotropic drugs might alter the frequency of NSSI in adolescents or if NSSI might indicate a transdiagnostic feature of more pronounced disease severity.

Key Words

non-suicidal self-harm - benzodiazepine - adolescents

^* Shared-first authorship: Vincent Eggart, Matin Mortazavi

Publication History

Received: 29 April 2023
Received: 02 August 2023

Accepted: 07 August 2023

Article published online:
18 September 2023

• References

• 1 Witt KG, Hetrick SE, Rajaram G. et al. Interventions for self-harm in children and adolescents. Cochrane Database Syst Rev 2021; 3: Cd013667 DOI: 10.1002/14651858.CD013667.pub2.
• 2 Klonsky ED, Victor SE, Saffer BY. Nonsuicidal self-injury: What we know, and what we need to know. Can J Psychiatry 2014; 59: 565-568 DOI: 10.1177/070674371405901101.
• 3 Zetterqvist M. The DSM-5 diagnosis of nonsuicidal self-injury disorder: A review of the empirical literature. Child Adolesc Psychiatry Ment Health 2015; 9: 31 DOI: 10.1186/s13034-015-0062-7.
• 4 Liu RT, Walsh RFL, Sheehan AE. et al. Prevalence and correlates of suicide and nonsuicidal self-injury in children: A systematic review and meta-analysis. JAMA Psychiatry 2022; 79: 718-726 DOI: 10.1001/jamapsychiatry.2022.1256.
• 5 Brown RC, Plener PL. Non-suicidal self-injury in adolescence. Curr Psychiatry Rep 2017; 19: 20 DOI: 10.1007/s11920-017-0767-9.
• 6 Ghinea D, Edinger A, Parzer P. et al. Non-suicidal self-injury disorder as a stand-alone diagnosis in a consecutive help-seeking sample of adolescents. J Affect Disord 2020; 274: 1122-1125 DOI: 10.1016/j.jad.2020.06.009.
• 7 Fox KR, Franklin JC, Ribeiro JD. et al. Meta-analysis of risk factors for nonsuicidal self-injury. Clin Psychol Rev 2015; 42: 156-167 DOI: 10.1016/j.cpr.2015.09.002.
• 8 Barrocas AL, Giletta M, Hankin BL. et al. Nonsuicidal self-injury in adolescence: Longitudinal course, trajectories, and intrapersonal predictors. J Abnorm Child Psychol 2015; 43: 369-380 DOI: 10.1007/s10802-014-9895-4.
• 9 Plener PL, Brunner R, Fegert JM. et al. Treating nonsuicidal self-injury (NSSI) in adolescents: Consensus based German guidelines. Child Adolesc Psychiatry Ment Health 2016; 10: 46
• 10 Kaess M. Self-harm: A transdiagnostic marker of psychopathology and suicide risk during the COVID-19 pandemic. Eur Child Adolesc Psychiatry 2022; 31: 1-3 DOI: 10.1007/s00787-022-02044-0.
• 11 National Institute for Health and Care Excellence: Self-harm: Assessment, management and preventing recurrence. London: National Institute for Health and Care Excellence (NICE) [NG225] Published: 07 September 2022 Copyright © NICE 2022.
• 12 Liu RT, Scopelliti KM, Pittman SK. et al. Childhood maltreatment and non-suicidal self-injury: A systematic review and meta-analysis. Lancet Psychiatry 2018; 5: 51-64 DOI: 10.1016/s2215-0366(17)30469-8.
• 13 Peng B, Li J, Liu H. et al. Childhood maltreatment, low serum cortisol levels, and non-suicidal self-injury in young adults with major depressive disorders. Front Pediatr 2022; 10: 822046 DOI: 10.3389/fped.2022.822046.
• 14 Qian H, Shu C, Feng L. et al. Childhood maltreatment, stressful life events, cognitive emotion regulation strategies, and non-suicidal self-injury in adolescents and young adults with first-episode depressive disorder: Direct and indirect pathways. Front Psychiatry 2022; 13: 838693 DOI: 10.3389/fpsyt.2022.838693.
• 15 Steinhoff A, Bechtiger L, Ribeaud D. et al. Stressful life events in different social contexts are associated with self-injury from early adolescence to early adulthood. Front Psychiatry 2020; 11: 487200 DOI: 10.3389/fpsyt.2020.487200.
• 16 Persico AM, Arango C, Buitelaar JK. et al. Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives. Eur Neuropsychopharmacol 2015; 25: 1513-1531 DOI: 10.1016/j.euroneuro.2015.06.009.
• 17 Becker K, Adam H, In-Albon T. et al. Diagnostik und therapie von suizidalität im jugendalter: Das wichtigste in kürze aus den aktuellen leitlinien. Z Kinder- Jugendpsychiatr Psychother 2017; 45: 485-97
• 18 Brent DA, Emslie GJ, Clarke GN. et al. Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study. Am J Psychiatry 2009; 166: 418-426 DOI: 10.1176/appi.ajp.2008.08070976.
• 19 Abbas SJB, Engel S, Günster C. et al. Psychopharmacological prescriptions in children and adolescents in Germany – a nationwide analysis of over 4 million statutory insured individuals from 2004 to 2012. Dtsch Arztebl Int 2016; 113: 396-403 DOI: 10.3238/arztebl.2016.0396.
• 20 Sidorchuk A, Isomura K, Molero Y. et al. Benzodiazepine prescribing for children, adolescents, and young adults from 2006 through 2013: A total population register-linkage study. PLoS Med 2018; 15: e1002635 DOI: 10.1371/journal.pmed.1002635.
• 21 Kandemir H, Yumru M, Kul M. et al. Behavioral disinhibition, suicidal ideation, and self-mutilation related to clonazepam. J Child Adolesc Psychopharmacol 2008; 18: 409 DOI: 10.1089/cap.2008.1854.
• 22 Commander M, Green SH, Prendergast M. Behavioural disturbances in children treated with clonazepam. Dev Med Child Neurol 1991; 33: 362-363 DOI: 10.1111/j.1469-8749.1991.tb14889.x.
• 23 Reiter S, Kutcher SP. Disinhibition and anger outbursts in adolescents treated with clonazepam. J Clin Psychopharmacol 1991; 11: 268 DOI: 10.1097/00004714-199108000-00016.
• 24 Tan KR, Brown M, Labouèbe G. et al. Neural bases for addictive properties of benzodiazepines. Nature 2010; 463: 769-774 DOI: 10.1038/nature08758.
• 25 Jones KA, Nielsen S, Bruno R. et al. Benzodiazepines – Their role in aggression and why GPs should prescribe with caution. Aust Fam Physician 2011; 40: 862-865
• 26 Lee R, Petty F, Coccaro EF. Cerebrospinal fluid GABA concentration: Relationship with impulsivity and history of suicidal behavior, but not aggression, in human subjects. J Psychiatr Res 2009; 43: 353-359 DOI: 10.1016/j.jpsychires.2008.04.004.
• 27 dosReis S, Barnett S, Love RC. et al. A guide for managing acute aggressive behavior of youths in residential and inpatient treatment facilities. Psychiatr Serv 2003; 54: 1357-1363 DOI: 10.1176/appi.ps.54.10.1357.
• 28 Albrecht B, Staiger PK, Hall K. et al. Benzodiazepine use and aggressive behaviour: A systematic review. Aust N Z J Psychiatry 2014; 48: 1096-1114 DOI: 10.1177/0004867414548902.
• 29 Goodyer IM, Wilkinson PO. Practitioner Review: Therapeutics of unipolar major depressions in adolescents. J Child Psychol Psychiatry 2019; 60: 232-243 DOI: 10.1111/jcpp.12940.
• 30 Eggart V, Cordier S, Hasan A. et al. Psychotropic drugs for the treatment of non-suicidal self-injury in children and adolescents: A systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci 2022; 272: 1559-1568 DOI: 10.1007/s00406-022-01385-w.
• 31 Benkert OHH. Kompendium der Psychiatrischen Pharmakotherapie 2021; DOI: 10.1007/978-3-662-61753-3_3.
• 32 Remschmidt HSM, Poustka F. Multiaxiales Klassifikationsschema für psychische Störungen des kinder- und jugendalters nach ICD-10 der WHO - Mit einem synoptischen vergleich von ICD-10 und DSM-IV. Bern: Huber Verlag; 2012
• 33 American Psychological Association. Guideline Development Panel for the Treatment of Depressive Disorders, Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts. Adopted as APA Policy. 2019
• 34 Cheung AH, Zuckerbrot RA, Jensen PS. et al. Guidelines for Adolescent Depression in Primary Care (GLAD-PC): II. Treatment and ongoing management. Pediatrics 2007; 120: e1313-1326 DOI: 10.1542/peds.2006-1395.
• 35 National Institute for Health and Care Excellence: Depression in children and young people: Identification and management. NICE guideline [NG134] Published date: 25 June 2019